Chromosome Microarray (CMA) Detection (3) - CapitalBio Technology Co., Ltd.

Testing Content

Detection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.

Testing Method

Sample Requirements

Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.

Reporting Cycle

10 working days

Clinical Application Overview

Assess chromosomal abnormalities and investigate the genetic causes of recurrent miscarriage and infertility.

PREV: Chromosome Microarray (CMA) Detection 2.0 (4)

NEXT: Chromosome Microarray (CMA) Detection

Related IVD Products

Related News Of IVD Technology

CapitalBio: Revolutionizing Genomics with Advanced Microarray ScannersFebruary 7, 2024Introduction to CapitalBio and Microarray TechnologyCapitalBio, a global leader in biotechnology, is revolutionizing the field of genomics with its advanced microarray scanners. These instruments, inc...view
Introduction of Cabin LaboratorySeptember 27, 20221. Definition of Cabin LaboratoryCabin laboratory is used for nucleic acid detection experiments, microorganism detection experiments, biochemical detection experiments, physical and chemical analysis...view
DNA Microarray Scanner Leads Innovation in Genetic Testing TechnologyApril 10, 2024With the rapid development of biotechnology, genetic testing technology is ushering in an unprecedented innovation. In this revolution, DNA microarray scanners have emerged as a leader due to their hi...view
Unlocking the Genetic Mysteries: How Genome Sequencing Services Can Reveal Your AncestryJune 26, 2023The human story is one that is intertwined with our past, our ancestry, and our origins. For centuries, individuals have sought to understand their family history and ancestral roots. Thanks to advanc...view
Microarray Chip Application Process and Data AnalysisDecember 15, 2022Microarray chip refers to the use of photoconductive in-situ synthesis or micro spotting to solidify a large number of biological macromolecules such as nucleic acid fragments, polypeptide molecules, ...view
Prostate Cancer (PCA) Is A Difficult Disease To UnderstandJune 28, 2022Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. On the other hand, non-genetic intra-t...view